Western tradition · Neurohormone

Melatonin

Beyond sleep: melatonin is a potent mitochondrial antioxidant whose production declines ~80% from youth to old age.

730ClinicalTrials.gov matched
1208PubMed RCT records
708Meta-analysis records
2+PubMed records
MelatoninKey active compound

Data definition. Matched records include all indexed medical endpoints for this intervention — not only longevity. Longevity-relevant records are screened separately and cited in the evidence summary below. Counts are matched-record volumes, not de-duplicated trials and not efficacy claims.

Origin & tradition

Not traditional as a supplement: melatonin's role as a sleep and circadian hormone was identified in the 1950s–60s.

Why longevity buyers care

Key active: Melatonin (N-acetyl-5-methoxytryptamine — pineal neurohormone).

Melatonin acts as a direct free-radical scavenger, mitochondrial membrane stabilizer, and circadian anchor. Its decline with age (~80% reduction) is considered a driver of circadian disruption and mitochondrial aging. Clinical trials cover sleep quality, cancer adjuvant, cardiovascular risk, and cognitive aging.

Effect summary

Studied health outcomes

Editorial summary — This table is curated by hand from published research consensus, not automatically calculated from our trial database. Grades reflect our interpretation of the literature. Treat as a starting point, not a definitive verdict. See the Evidence panel below for the underlying trial and paper counts sourced directly from ClinicalTrials.gov and PubMed.
Health outcomeEffectMagnitudeGrade
Sleep onset latency↓DecreasesStrongA
Jet lag recovery↑IncreasesStrongA
Circadian rhythm phase shift↑IncreasesStrongA
Antioxidant / mitochondrial protection↑IncreasesModerateB
Sleep quality (total)↑IncreasesModerateB
Human lifespan / healthspan extension→No changeNegligibleD

Grade: A = robust RCTs · B = several RCTs / meta-analysis · C = limited or mixed RCTs · D = observational or early data

Dosage guidance

How Melatonin is typically used

Typical dose
0.5–3 mg/night (lowest effective dose)
Form
immediate-release tablet or sublingual
Timing
30–60 minutes before intended sleep time

More is not better — 0.5mg is often as effective as 5–10mg for sleep onset, with fewer next-day effects. High doses suppress endogenous melatonin production. Use the lowest dose that works. Extended-release may help with sleep maintenance.

Informational only — not a prescription or personalised medical advice. Consult a qualified clinician before starting any supplement or medication.

Evidence summary

What the research actually says

82Evidence confidence
Extensive human-trial evidence1,208 randomized controlled trials · 708 meta-analyses / systematic reviews

Extensive human RCTs on sleep; growing trial base for aging endpoints

Melatonin acts as a direct free-radical scavenger, mitochondrial membrane stabilizer, and circadian anchor. Its decline with age (~80% reduction) is considered a driver of circadian disruption and mitochondrial aging. Clinical trials cover sleep quality, cancer adjuvant, cardiovascular risk, and cognitive aging.

730registered clinical trials reference this intervention
    2selected from 2+ PubMed papers (longevity / aging angle)
    Key active: Melatonin (N-acetyl-5-methoxytryptamine — pineal neurohormone).

    According to PubMed and ClinicalTrials.gov: trial counts from ClinicalTrials.gov, peer-reviewed literature from PubMed. Counts auto-refresh weekly; last checked 2026-11-16. They include trials across many endpoints, not only longevity.

    Informational only — not medical advice, a treatment claim, or a substitute for a qualified clinician. Evidence strength varies; we show mixed and null results on purpose.

    Suppliers

    No Melatonin suppliers listed yet

    Tell us what you need and we will source suppliers for you.

    Request sourcing help